[go: up one dir, main page]

AU6722300A - Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders - Google Patents

Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders

Info

Publication number
AU6722300A
AU6722300A AU67223/00A AU6722300A AU6722300A AU 6722300 A AU6722300 A AU 6722300A AU 67223/00 A AU67223/00 A AU 67223/00A AU 6722300 A AU6722300 A AU 6722300A AU 6722300 A AU6722300 A AU 6722300A
Authority
AU
Australia
Prior art keywords
diagnosing
peptides
substances
methods
devices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67223/00A
Inventor
Daniel M. Michaelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ramot at Tel Aviv University Ltd
Original Assignee
Ramot at Tel Aviv University Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramot at Tel Aviv University Ltd filed Critical Ramot at Tel Aviv University Ltd
Publication of AU6722300A publication Critical patent/AU6722300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU67223/00A 1999-08-31 2000-08-27 Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders Abandoned AU6722300A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38634799A 1999-08-31 1999-08-31
US09/386347 1999-08-31
US22115000P 2000-07-27 2000-07-27
US60/221150 2000-07-27
PCT/IL2000/000509 WO2001015655A2 (en) 1999-08-31 2000-08-27 Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders

Publications (1)

Publication Number Publication Date
AU6722300A true AU6722300A (en) 2001-03-26

Family

ID=26915543

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67223/00A Abandoned AU6722300A (en) 1999-08-31 2000-08-27 Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders

Country Status (3)

Country Link
EP (1) EP1209969A2 (en)
AU (1) AU6722300A (en)
WO (1) WO2001015655A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784568B2 (en) * 1999-09-03 2006-05-04 Ramot At Tel-Aviv University Ltd Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
US20060003381A1 (en) * 2001-05-03 2006-01-05 James Gilmore Methods for assembling protein microarrays
AR038568A1 (en) * 2002-02-20 2005-01-19 Hoffmann La Roche ANTI-A BETA ANTIBODIES AND ITS USE
GB0314943D0 (en) * 2003-06-25 2003-07-30 Proteome Sciences Plc Screening methods
ES2368591T3 (en) 2005-12-12 2011-11-18 F. Hoffmann-La Roche Ag ANTIBODIES AGAINST AMYLOID BETA WITH GLYCOSILATION IN THE VARIABLE REGION.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU667530B2 (en) * 1992-05-28 1996-03-28 New York Blood Center, Inc., The Removal of antibodies from blood-derived compositions while retaining coagulation factors

Also Published As

Publication number Publication date
EP1209969A2 (en) 2002-06-05
WO2001015655A3 (en) 2001-11-22
WO2001015655A2 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
AU6604800A (en) Cleaning system, device and method
AU4545400A (en) Vehicle treatment system and method for operating the same
EP1031640B8 (en) Trap apparatus
AU2003286611A1 (en) Cytomodulating peptides and methods for treating neurological disorders
AU2595397A (en) Apparatus for treating neurodegenerative disorders
AU1579697A (en) Semiconductor devices, and methods for same
AU7357000A (en) Filter and valve apparatus
ZA986072B (en) Adsorption apparatus and methods.
AU3027799A (en) Device for treating hair
AU2002334687A1 (en) Ventricular infarct assist device and methods for using it
AU3193800A (en) Exposure method, illuminating device, and exposure system
AU8676698A (en) Devices for providing therapeutic substances
AU4784500A (en) Reduction apparatus
AU6894600A (en) Therapeutic polypeptides and methods for using same
AU7823098A (en) Methods for treating obesity
AU5838700A (en) Method for treating and preventing finger disorders
AU5787999A (en) Method for treating neurodegenerative disorders
AU3263097A (en) Portable, secure transaction system for programmable, intelligent devices
AU3339399A (en) Fail-safe device
AU6722300A (en) Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders
AU2631895A (en) Fixing device, and method for the manufacture thereof
EP1102217A3 (en) Verification device
AU5855899A (en) Method for identifying substances for the treatment of c-jun-mediated disorders
AU3429300A (en) Means for diagnosing and treating carcinoma
AU1081701A (en) Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase